Lucid Diagnostics (LUCD) Other Accumulated Expenses (2021 - 2024)
Lucid Diagnostics (LUCD) posted Other Accumulated Expenses of $869000.0 for Q4 2024, up 1539.62% on a QoQ basis from $53000.0 in Q3 2024, and up 805.21% year-over-year from $96000.0 in Q1 2024.
Lucid Diagnostics (LUCD) Other Accumulated Expenses (2021 - 2024) Analysis & Trends
Lucid Diagnostics' Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $869000.0 for Q4 2024.
- Quarterly Other Accumulated Expenses rose 805.21% year-over-year to $869000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $869000.0 (up 805.21% YoY) and the FY2024 annual result came in at $869000.0, up 805.21% from the prior year.
- Other Accumulated Expenses was $869000.0 for Q4 2024 at Lucid Diagnostics, up from $53000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $10.3 million in Q3 2023 and bottomed at $25000.0 in Q4 2021.
- A 4-year average of $2.3 million and a median of $567500.0 in 2024 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses surged 19740.0% — and 2024, when it slumped 99.48%.
- Lucid Diagnostics' Other Accumulated Expenses stood at $25000.0 in 2021, then jumped by 19740.0% to $5.0 million in 2022, then sank by 98.06% to $96000.0 in 2023, then soared by 805.21% to $869000.0 in 2024.
- Business Quant data shows LUCD's Other Accumulated Expenses at $869000.0 in Q4 2024, $53000.0 in Q3 2024, and $266000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 869,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 266,000.00 |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | 10.29 Mn |
| Dec 31, 2022 | 4.96 Mn |
| Dec 31, 2021 | 25,000.00 |